Fresenius Medical Care AG & Co. KGaA

$ 37.77 0.36 (0.96%)
Volume: 260,801 Avg Vol (1m): 257,664
Market Cap $: 23.06 Bil Enterprise Value $: 38.05 Bil
P/E (TTM): 10.50 P/B: 1.71
Earnings Power Value 6.54
Net Current Asset Value -23.42
Tangible Book -5.38
Projected FCF 39
Median P/S Value 45.16
Graham Number 0
Peter Lynch Value 43.14
DCF (FCF Based) 34.22
DCF (Earnings Based) 52.43
1Y (-%)

Financial Strength : 5/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 0.07
Cash-To-Debt ranked lower than
64.96% of 274 companies
in the Medical Care industry.
Industry Max: 10000, Med: 0.28, Min: 0.01
FMS: 0.07
Ranked among companies with meaningful Cash-To-Debt only.
Cash-To-Debt range over the past 10 years
Min: 0.02, Med: 0.06, Max: 0.3
Current: 0.07
0.02
0.3
Equity-to-Asset 0.37
Equity-to-Asset ranked lower than
60.59% of 269 companies
in the Medical Care industry.
Industry Max: 0.97, Med: 0.48, Min: -15.93
FMS: 0.37
Ranked among companies with meaningful Equity-to-Asset only.
Equity-to-Asset range over the past 10 years
Min: 0.34, Med: 0.4, Max: 0.5
Current: 0.37
0.34
0.5
Debt-to-Equity 1.10
Debt-to-Equity ranked lower than
55.94% of 202 companies
in the Medical Care industry.
Industry Max: 25.64, Med: 0.64, Min: 0.01
FMS: 1.1
Ranked among companies with meaningful Debt-to-Equity only.
Debt-to-Equity range over the past 10 years
Min: 0.25, Med: 0.81, Max: 1.1
Current: 1.1
0.25
1.1
Debt-to-EBITDA 3.20
Debt-to-EBITDA ranked higher than
56.72% of 201 companies
in the Medical Care industry.
Industry Max: 66.84, Med: 2.81, Min: 0.01
FMS: 3.2
Ranked among companies with meaningful Debt-to-EBITDA only.
Debt-to-EBITDA range over the past 10 years
Min: 1.93, Med: 2.62, Max: 3.2
Current: 3.2
1.93
3.2
Interest Coverage 4.54
Interest Coverage ranked lower than
55.07% of 227 companies
in the Medical Care industry.
Industry Max: 48765, Med: 6.85, Min: 0.01
FMS: 4.54
Ranked among companies with meaningful Interest Coverage only.
Interest Coverage range over the past 10 years
Min: 4.5, Med: 5.22, Max: 6.27
Current: 4.54
4.5
6.27
Piotroski F-Score 5
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.88
DISTRESS
GREY
SAFE
Beneish M-Score -2.60
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC 9.78%
WACC 6.87%

Profitability & Growth : 8/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % 13.05
Operating Margin ranked higher than
69.85% of 272 companies
in the Medical Care industry.
Industry Max: 66.83, Med: 6.83, Min: -3742
FMS: 13.05
Ranked among companies with meaningful Operating Margin only.
Operating Margin range over the past 10 years
Min: 12.76, Med: 14.68, Max: 16.22
Current: 13.05
12.76
16.22
Net Margin % 11.82
Net Margin ranked higher than
67.28% of 272 companies
in the Medical Care industry.
Industry Max: 202.55, Med: 3.88, Min: -4897.7
FMS: 11.82
Ranked among companies with meaningful Net Margin only.
Net Margin range over the past 10 years
Min: 6.18, Med: 7.76, Max: 11.98
Current: 11.82
6.18
11.98
ROE % 17.37
ROE ranked higher than
67.84% of 255 companies
in the Medical Care industry.
Industry Max: 73.04, Med: 8.03, Min: -4811.69
FMS: 17.37
Ranked among companies with meaningful ROE only.
ROE range over the past 10 years
Min: 11.36, Med: 13.42, Max: 18.37
Current: 17.37
11.36
18.37
ROA % 7.40
ROA ranked higher than
62.64% of 273 companies
in the Medical Care industry.
Industry Max: 52.42, Med: 3.48, Min: -3383.78
FMS: 7.4
Ranked among companies with meaningful ROA only.
ROA range over the past 10 years
Min: 4.33, Med: 5.4, Max: 7.89
Current: 7.4
4.33
7.89
ROC (Joel Greenblatt) % 65.87
ROC (Joel Greenblatt) ranked higher than
77.21% of 272 companies
in the Medical Care industry.
Industry Max: 8470.37, Med: 14.91, Min: -33236.56
FMS: 65.87
Ranked among companies with meaningful ROC (Joel Greenblatt) only.
ROC (Joel Greenblatt) range over the past 10 years
Min: 40, Med: 47.92, Max: 65.87
Current: 65.87
40
65.87
3-Year Total Revenue Growth Rate 2.30
3-Year Revenue Growth Rate ranked higher than
66.35% of 211 companies
in the Medical Care industry.
Industry Max: 314.7, Med: 6.5, Min: -100
FMS: 2.1
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
3-Year Revenue Growth Rate range over the past 10 years
Min: -18.1, Med: 8.9, Max: 22.3
Current: 2.1
-18.1
22.3
3-Year Total EBITDA Growth Rate 10.70
3-Year EBITDA Growth Rate ranked higher than
55.43% of 184 companies
in the Medical Care industry.
Industry Max: 236.4, Med: 5.9, Min: -108
FMS: 10.5
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
3-Year EBITDA Growth Rate range over the past 10 years
Min: -30.3, Med: 7.4, Max: 22.4
Current: 10.5
-30.3
22.4
3-Year EPS w/o NRI Growth Rate 27.30
3-Year EPS w/o NRI Growth Rate ranked higher than
61.11% of 162 companies
in the Medical Care industry.
Industry Max: 136.6, Med: 8.4, Min: -146.6
FMS: 27.3
Ranked among companies with meaningful 3-Year EPS w/o NRI Growth Rate only.
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: 0, Med: 13.6, Max: 61.9
Current: 27.3
0
61.9

» FMS's 30-Y Financials

Financials (Next Earnings Date: 2019-07-30)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NYSE:FMS

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Health Care Providers » Medical Care    NAICS : 621492    SIC : 8092
Compare BKK:BDMS SZSE:300015 XKLS:5225 NYSE:UHS XTER:FREA ASX:RHC ASX:SHL NYSE:DVA LSE:NMC BSP:HAPV3 NYSE:EHC NYSE:EVHC NYSE:CHE BKK:BH-Q NYSE:HCA NAS:LHCG NAS:AMED LSE:MDC ASX:HSO NAS:ACHC
Traded in other countries FME.Austria FMEN.Germany FME.Italy FMEN.Mexico FME.Switzerland 0H9X.UK
Address Else-Kroener-Strasse 1, Bad Homburg, DEU, 61352
Based in Germany, Fresenius Medical Care is the largest global dialysis provider, with over 300,000 patients in North America, Europe, Latin America, and Asia. Fresenius operates over 2,270 clinics in North America, 700 in Europe, 360 in Asia-Pacific, and 230 in Latin America. Fresenius also sells dialysis machines and disposables, which represent nearly 20% of the company's revenue.

Ratios

Current vs industry vs history
PE Ratio (TTM) 10.50
PE Ratio ranked higher than
69.19% of 198 companies
in the Medical Care industry.
Industry Max: 6430, Med: 27.31, Min: 1.39
FMS: 10.5
Ranked among companies with meaningful PE Ratio only.
PE Ratio range over the past 10 years
Min: 8.78, Med: 19.6, Max: 29.11
Current: 10.5
8.78
29.11
Forward PE Ratio 15.24
Forward P/E ranked higher than
59.32% of 59 companies
in the Medical Care industry.
Industry Max: 107.53, Med: 20.66, Min: 8.31
FMS: 15.24
Ranked among companies with meaningful Forward P/E only.
N/A
PE Ratio without NRI 10.50
PE without NRI ranked higher than
68.69% of 198 companies
in the Medical Care industry.
Industry Max: 6430, Med: 9999, Min: 1.39
FMS: 10.5
Ranked among companies with meaningful PE without NRI only.
PE without NRI range over the past 10 years
Min: 8.78, Med: 19.6, Max: 29.11
Current: 10.5
8.78
29.11
Price-to-Owner-Earnings 7.92
Price-to-Owner-Earnings ranked higher than
83.49% of 109 companies
in the Medical Care industry.
Industry Max: 8000, Med: 26.64, Min: 1.5
FMS: 7.92
Ranked among companies with meaningful Price-to-Owner-Earnings only.
Price-to-Owner-Earnings range over the past 10 years
Min: 7.12, Med: 17.64, Max: 33.96
Current: 7.92
7.12
33.96
PB Ratio 1.71
PB Ratio ranked lower than
50.59% of 253 companies
in the Medical Care industry.
Industry Max: 48, Med: 2.64, Min: 0.05
FMS: 1.71
Ranked among companies with meaningful PB Ratio only.
PB Ratio range over the past 10 years
Min: 1.48, Med: 2.43, Max: 3.03
Current: 1.71
1.48
3.03
PS Ratio 1.24
PS Ratio ranked higher than
57.63% of 262 companies
in the Medical Care industry.
Industry Max: 79.41, Med: 1.7, Min: 0.03
FMS: 1.24
Ranked among companies with meaningful PS Ratio only.
PS Ratio range over the past 10 years
Min: 1.03, Med: 1.48, Max: 1.84
Current: 1.24
1.03
1.84
Price-to-Free-Cash-Flow 18.07
Price-to-Free-Cash-Flow ranked higher than
59.26% of 135 companies
in the Medical Care industry.
Industry Max: 777.22, Med: 23.01, Min: 1.25
FMS: 18.07
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
Price-to-Free-Cash-Flow range over the past 10 years
Min: 14.36, Med: 23.43, Max: 50.09
Current: 18.07
14.36
50.09
Price-to-Operating-Cash-Flow 9.50
Price-to-Operating-Cash-Flow ranked higher than
59.14% of 186 companies
in the Medical Care industry.
Industry Max: 1706.9, Med: 14.67, Min: 0.7
FMS: 9.5
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 8.44, Med: 12.28, Max: 19.61
Current: 9.5
8.44
19.61
EV-to-EBIT 10.52
EV-to-EBIT ranked higher than
78.97% of 214 companies
in the Medical Care industry.
Industry Max: 3101.61, Med: 21.68, Min: 1.06
FMS: 10.52
Ranked among companies with meaningful EV-to-EBIT only.
EV-to-EBIT range over the past 10 years
Min: 7.2, Med: 12.6, Max: 16.2
Current: 10.52
7.2
16.2
EV-to-EBITDA 8.20
EV-to-EBITDA ranked higher than
75.44% of 228 companies
in the Medical Care industry.
Industry Max: 1827.89, Med: 15.23, Min: 0.9
FMS: 8.2
Ranked among companies with meaningful EV-to-EBITDA only.
EV-to-EBITDA range over the past 10 years
Min: 5.8, Med: 9.9, Max: 12.5
Current: 8.2
5.8
12.5
EV-to-Revenue 2.03
EV-to-Revenue ranked higher than
54.24% of 271 companies
in the Medical Care industry.
Industry Max: 158.19, Med: 2.17, Min: 0.06
FMS: 2.03
Ranked among companies with meaningful EV-to-Revenue only.
EV-to-Revenue range over the past 10 years
Min: 1.2, Med: 2, Max: 2.4
Current: 2.03
1.2
2.4
PEG Ratio 0.93
PEG Ratio ranked higher than
59.79% of 97 companies
in the Medical Care industry.
Industry Max: 497.4, Med: 3.13, Min: 0.11
FMS: 0.93
Ranked among companies with meaningful PEG Ratio only.
PEG Ratio range over the past 10 years
Min: 0.74, Med: 1.86, Max: 4.76
Current: 0.93
0.74
4.76
Shiller PE Ratio 18.73
Shiller PE Ratio ranked higher than
62.90% of 62 companies
in the Medical Care industry.
Industry Max: 1305.92, Med: 31.76, Min: 8.18
FMS: 18.73
Ranked among companies with meaningful Shiller PE Ratio only.
Shiller PE Ratio range over the past 10 years
Min: 16.18, Med: 27.75, Max: 34.94
Current: 18.73
16.18
34.94
Current Ratio 1.02
Current Ratio ranked lower than
57.31% of 260 companies
in the Medical Care industry.
Industry Max: 13.59, Med: 1.34, Min: 0.04
FMS: 1.02
Ranked among companies with meaningful Current Ratio only.
Current Ratio range over the past 10 years
Min: 0.8, Med: 1.38, Max: 1.93
Current: 1.02
0.8
1.93
Quick Ratio 0.79
Quick Ratio ranked lower than
60.38% of 260 companies
in the Medical Care industry.
Industry Max: 13.59, Med: 1.24, Min: 0.04
FMS: 0.79
Ranked among companies with meaningful Quick Ratio only.
Quick Ratio range over the past 10 years
Min: 0.7, Med: 1.15, Max: 1.61
Current: 0.79
0.7
1.61
Days Inventory 38.19
Days Inventory ranked lower than
73.30% of 206 companies
in the Medical Care industry.
Industry Max: 464.03, Med: 17.07, Min: 0.09
FMS: 38.19
Ranked among companies with meaningful Days Inventory only.
Days Inventory range over the past 10 years
Min: 35.06, Med: 39.14, Max: 44.18
Current: 38.19
35.06
44.18
Days Sales Outstanding 83.32
Days Sales Outstanding ranked lower than
81.06% of 227 companies
in the Medical Care industry.
Industry Max: 524.5, Med: 39.87, Min: 0.25
FMS: 83.32
Ranked among companies with meaningful Days Sales Outstanding only.
Days Sales Outstanding range over the past 10 years
Min: 69.56, Med: 76.39, Max: 83.32
Current: 83.32
69.56
83.32
Days Payable 22.49
Days Payable ranked lower than
77.27% of 176 companies
in the Medical Care industry.
Industry Max: 1871.61, Med: 40.58, Min: 1
FMS: 22.49
Ranked among companies with meaningful Days Payable only.
Days Payable range over the past 10 years
Min: 17.84, Med: 19.69, Max: 24.69
Current: 22.49
17.84
24.69

Dividend & Buy Back

Current vs industry vs history
Dividend Yield % 1.74
Trailing Dividend Yield ranked lower than
68.92% of 251 companies
in the Medical Care industry.
Industry Max: 1324.37, Med: 1.79, Min: 0.07
FMS: 1.74
Ranked among companies with meaningful Trailing Dividend Yield only.
Trailing Dividend Yield range over the past 10 years
Min: 0.94, Med: 1.31, Max: 2.07
Current: 1.74
0.94
2.07
Dividend Payout Ratio 0.17
Dividend Payout Ratio ranked higher than
79.35% of 155 companies
in the Medical Care industry.
Industry Max: 21.34, Med: 0.43, Min: 0.03
FMS: 0.17
Ranked among companies with meaningful Dividend Payout Ratio only.
Dividend Payout Ratio range over the past 10 years
Min: 0.16, Med: 0.24, Max: 0.28
Current: 0.17
0.16
0.28
3-Year Dividend Growth Rate (Per Share) 10.80
3-Year Dividend Growth Rate ranked lower than
55.29% of 85 companies
in the Medical Care industry.
Industry Max: 96.1, Med: 8.7, Min: -100
FMS: 10.8
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
3-Year Dividend Growth Rate range over the past 10 years
Min: 0, Med: 7.6, Max: 13.1
Current: 10.8
0
13.1
Forward Dividend Yield % 1.75
Forward Dividend Yield ranked lower than
66.53% of 251 companies
in the Medical Care industry.
Industry Max: 9.57, Med: 1.99, Min: 0.12
FMS: 1.75
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield-on-Cost (5-Year) % 2.46
Yield-on-Cost (5y) ranked lower than
66.77% of 325 companies
in the Medical Care industry.
Industry Max: 1324.37, Med: 2.24, Min: 0.03
FMS: 2.46
Ranked among companies with meaningful Yield-on-Cost (5y) only.
Yield-on-Cost (5y) range over the past 10 years
Min: 1.33, Med: 1.85, Max: 2.93
Current: 2.46
1.33
2.93
3-Year Share Buyback Rate -0.20
3-Year Share Buyback Rate ranked higher than
70.44% of 159 companies
in the Medical Care industry.
Industry Max: 100, Med: -2.5, Min: -549.3
FMS: -0.2
Ranked among companies with meaningful 3-Year Share Buyback Rate only.
3-Year Share Buyback Rate range over the past 10 years
Min: -11.8, Med: -0.5, Max: 8
Current: -0.2
-11.8
8

Valuation & Return

Current vs industry vs history
Price-to-Projected-FCF 0.97
Price-to-Intrinsic-Value-Projected-FCF ranked higher than
75.25% of 101 companies
in the Medical Care industry.
Industry Max: 20.14, Med: 1.98, Min: 0.07
FMS: 0.97
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
Price-to-Intrinsic-Value-Projected-FCF range over the past 10 years
Min: 0.79, Med: 1.34, Max: 2.15
Current: 0.97
0.79
2.15
Price-to-DCF (Earnings Based) 0.72
Price-to-Intrinsic-Value-DCF (Earnings Based) ranked higher than
57.58% of 33 companies
in the Medical Care industry.
Industry Max: 6.43, Med: 1.81, Min: 0.5
FMS: 0.72
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
Price-to-Intrinsic-Value-DCF (Earnings Based) range over the past 10 years
Min: 0.6, Med: 1.46, Max: 1.8
Current: 0.72
0.6
1.8
Price-to-Median-PS-Value 0.84
Price-to-Median-PS-Value ranked higher than
58.65% of 208 companies
in the Medical Care industry.
Industry Max: 12, Med: 1.03, Min: 0.01
FMS: 0.84
Ranked among companies with meaningful Price-to-Median-PS-Value only.
Price-to-Median-PS-Value range over the past 10 years
Min: 0.19, Med: 0.99, Max: 1.72
Current: 0.84
0.19
1.72
Price-to-Peter-Lynch-Fair-Value 0.88
Price-to-Peter-Lynch-Fair-Value ranked higher than
58.18% of 55 companies
in the Medical Care industry.
Industry Max: 23.11, Med: 2.08, Min: 0.48
FMS: 0.88
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
Price-to-Peter-Lynch-Fair-Value range over the past 10 years
Min: 0.31, Med: 1.85, Max: 4.5
Current: 0.88
0.31
4.5
Earnings Yield (Joel Greenblatt) % 9.51
Earnings Yield (Greenblatt) ranked higher than
83.52% of 273 companies
in the Medical Care industry.
Industry Max: 94.34, Med: 3.61, Min: -217.39
FMS: 9.51
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
Earnings Yield (Greenblatt) range over the past 10 years
Min: 6.2, Med: 7.9, Max: 13.8
Current: 9.51
6.2
13.8
Forward Rate of Return (Yacktman) % 16.27
Forward Rate of Return ranked higher than
69.92% of 133 companies
in the Medical Care industry.
Industry Max: 868.48, Med: 9.1, Min: -81.77
FMS: 16.27
Ranked among companies with meaningful Forward Rate of Return only.
Forward Rate of Return range over the past 10 years
Min: 9.4, Med: 14.1, Max: 19
Current: 16.27
9.4
19

More Statistics

Revenue (TTM) (Mil) $ 19,218.63
EPS (TTM) $ 3.71
Beta 1.93
Volatility % 39.17
52-Week Range $ 30.99 - 53.4
Shares Outstanding (Mil) 610.56

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 5
Positive ROA Y
Positive CFROA Y
Higher ROA yoy Y
CFROA > ROA Y
Lower Leverage yoy N
Higher Current Ratio yoy N
Less Shares Outstanding yoy N
Higher Gross Margin yoy N
Higher Asset Turnover yoy Y